ANDA 73516, held by Teva. Ketoprofen.
As of Nov 15, 2026, ANDA 73516 (Ketoprofen), held by Teva, was first approved by FDA on Dec 22, 1992, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 22, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ketoprofen50MG · capsule;oral | Ketoprofen | Rx |
| Nov 21, 2024 | Supplement 31Labeling · Standard review | Approved | None posted |
| Apr 28, 2021 | Supplement 30Labeling · Standard review | Approved | None posted |
| May 9, 2016 | Supplement 28Labeling · Standard review | Approved | None posted |
| Nov 29, 2006 | Supplement 23Labeling | Approved | None posted |
| Mar 8, 2006 | Supplement 21Labeling | Approved | None posted |
| Oct 24, 2001 | Supplement 16Manufacturing | Approved | None posted |
| Jul 7, 2000 | Supplement 15Manufacturing | Approved | None posted |
| Jan 14, 2000 | Supplement 14Manufacturing | Approved | None posted |
| Mar 26, 1999 | Supplement 13Manufacturing | Approved | None posted |
| Jul 14, 1998 | Supplement 12Manufacturing | Approved | None posted |
| Mar 17, 1998 | Supplement 9Labeling | Approved | None posted |
| Dec 10, 1997 | Supplement 11Manufacturing | Approved | None posted |
| May 13, 1997 | Supplement 10Manufacturing | Approved | None posted |
| Mar 14, 1997 | Supplement 8Manufacturing | Approved | None posted |
| Mar 14, 1997 | Supplement 7Manufacturing | Approved | None posted |
| Jul 31, 1995 | Supplement 5Manufacturing | Approved | None posted |
| Feb 16, 1995 | Supplement 3Manufacturing | Approved | None posted |
| Sep 6, 1994 | Supplement 2Manufacturing | Approved | None posted |
| Jul 15, 1994 | Supplement 1Manufacturing | Approved | None posted |
| Dec 22, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters